# Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer

> **NCT01379976** · PHASE3 · TERMINATED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 107 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Acetylcarnitine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01379976
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 107 (ACTUAL)
- **Why stopped:** Recruitment was prematurely stopped due to difficulty of recruitment encountered by the experimental centers
- **Last updated:** 2015-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01379976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01379976, "Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01379976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*